Avastin: drug regulator clears way for use for wet AMD
The NHS was now in a better position to treat thousands of patients with wet age-related macular degeneration “for a fraction of the cost,” Julie Wood, chief executive of NHS Clinical Commissioners,…
Read Original Article: Avastin: drug regulator clears way for use for wet AMD »
